Skip to search formSkip to main contentSkip to account menu

response to gemcitabine

Known as: response to 2',2'-difluorodeoxycytidine, response to 2'-deoxy-2',2'-difluorocytidine 
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Enhancement of Soft Tissue Sarcoma Response to Gemcitabine through Timed Administration of a Short-Acting Anti-Angiogenic Agent.
BACKGROUND/AIMS Despite enormous effort, anti-angiogenic drugs have not lived up to the promise of globally-enhancing anti-cancer… 
2019
2019
Synthesis and Evaluation of Novel Iodine-124 Labeled Nucleoside Analogs as Pet Imaging Agents to Predict Response to Gemcitabine Therapy
2015
2015
Differential Gene Expression of Pancreatic Cancer Cell Line Capan-2 in Response to Gemcitabine plus BVDU (RP101) Combinatorial Treatment
Every year worldwide approximately 3 million cancer patients receive chemotherapy. Unfortunately in many cases the treatment does… 
2015
2015
[A Patient with Recurrent Ovarian Cancer Who Was Hypersensitive to Carboplatin Exhibited Complete Response to Gemcitabine and Nedaplatin].
A 57-year-old multiparous woman with FIGO stage IV ovarian cancer underwent primary surgery and was administered postoperative… 
2012
2012
Significant Response to Gemcitabine Monotherapy in Primary Pleural Epithelioid Angiosarcoma
REFERENCES 1. Lynch TJ, Bell DW, Sordella R, et al. Activating mutations in the epidermal growth factor receptor underlying… 
2012
2012
A Case of Recurrent Gallbladder Cancer with Complete Response to Gemcitabine plus S-1 Combination Chemotherapy
Abstract Prognosis of biliary tract cancer has generally been poor, and effective chemotherapy has not yet been established. A 64… 
2011
2011
Smac Mimetic Improves Response To Gemcitabine And Docetaxel In Experimental Pancreatic Cancer
2009
2009
163 Ribonulceotide Reductase M2 (RRM2): Predictive Marker of Response to Gemcitabine in Pancreatic Cancer
2005
2005
CORRELATION OF GENE EXPRESSION PROFILES WITH CLINICAL RESPONSE TO GEMCITABINE IN PANCREATIC CANCER
2004
2004
Excellent Response to Gemcitabine in a Massively Pre-Treated Woman with Extensive Cutaneous Involvement after Recurrence of Breast Cancer
A 50-year-old woman presented with local relapse ofbreast cancer 6 years after partial mastectomy. Relapse wasaccompanied by… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)